Capabilities · Analytical & stability services

Stability studies

A proposed analytical service domain connecting protocol design, controlled storage, scheduled sampling and the evaluation of product characteristics over time.

PlannedCatalogue scope

Illustrative unbranded autosampler vial detail.
Illustrative unbranded autosampler vial detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Stability studies are presented as a planned service domain. The exact product, container-closure system, climatic zone and testing interval would define the applicable analytical scope.

The proposed services catalogue introduces this testing capability for technical discussion. The initial project plan does not identify stability studies as a service line, and any addition would require scope confirmation.

Accelerated, long-term and in-use stability evaluations serve distinct regulatory purposes. Inclusion in a common catalogue does not establish that all storage conditions are available for a specific project.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Finished dosage formsEvaluation of final product presentations in their intended commercial packaging.Catalogue scopePlanned
Active pharmaceutical ingredientsSmall-molecule active ingredientsDegradation studies and retest period determination for proposed drug substances.Catalogue scopePlanned
Clinical trial materialsClinical & investigational supply developmentShelf-life assessment and temperature excursion data for investigational medicinal products.Catalogue scopePlanned
Bulk intermediate productsHold-time studies for intermediate materials before final formulation and filling.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Protocol design & approval

Define the required testing intervals, storage conditions, analytical methods and relevant acceptance criteria.

02 · Process stage

Planned

Sample receipt & inventory

Establish secure handling processes, material accountability and controlled placement into designated chambers.

03 · Process stage

Planned

Controlled storage execution

Maintain the required temperature and humidity parameters with continuous environmental monitoring and alarm systems.

04 · Process stage

Planned

Scheduled analytical testing

Withdraw samples at the specified time points and execute the defined analytical testing procedures.

05 · Process stage

Planned

Data trending & evaluation

Analyse the analytical results for out-of-specification occurrences, degradation pathways and overall shelf-life projections.

06 · Process stage

Planned

Final report generation

Connect the protocol requirements, accumulated analytical data and the concluding stability evaluation.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Analytical method development

Product-specific test methods and analytical development questions.

Explore proposed scope

02PlannedCatalogue scope

Container-closure development

Compatibility, presentation and container-closure questions for the exact product.

Explore proposed scope

03PlannedCatalogue scope

Regulatory dossier support

Product-specific document structures and evidence requirements.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Product characteristics
Exact formulation, packaging materials and the intended commercial climatic zone.
Facility & equipment
Qualified climatic chambers, monitoring systems and appropriate backup power provisions.
Analytical methods
Stability-indicating testing procedures, complete validation data and defined acceptance criteria.
Quality responsibilities
Accountability for chamber excursions, sample integrity and final data review.
Regulatory context
Applicable guidance for relevant climatic zones and desired shelf-life claims.
Technical agreement
Study responsibilities, reporting milestones and boundaries for any analytical engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating stability testing service.

Do stability operations belong to the initial Boten plan?

No. The initial plan identifies manufacturing modules. Stability storage and testing are proposed catalogue additions requiring separate technical confirmation.

What information helps define the question?

Identify the product, container system, desired climatic conditions, required duration and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual analytical service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, chamber permissions, validated methods and an agreement would need to be established before a service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma